✦ LIBER ✦

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group

✍ Scribed by Bairey, Osnat; Goldschmidt, Neta; Ruchlemer, Rosa; Tadmor, Tamar; Rahimi-Levene, Neomi; Yuklea, Mona; Shvidel, Lev; Berrebi, Alain; Polliack, Aaron; Herishanu, Yair

Book ID: 119828187
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 144 KB
Volume: 89
Category: Article
ISSN: 0902-4441
DOI: 10.1111/ejh.12015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bendamustine in Combination With Rituxim

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pflug 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

Lenalidomide and Rituximab for the Initi

Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium

✍ James, D. F.; Werner, L.; Brown, J. R.; Wierda, W. G.; Barrientos, J. C.; Castro 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 576 KB

A study of allergy in patients with mali

A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia

✍ David P. McCormick; Arthur J. Ammann; Kimishige Ishizaka; Daniel G. Miller; Rich 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 534 KB

Subcutaneous Alemtuzumab in Fludarabine-

Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group

✍ Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buhler, A.; Schlenk, R. F.; Groner, S.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 170 KB

Subcutaneous Alemtuzumab in Fludarabine-

✍ Stilgenbauer, S.; Zenz, T.; Winkler, D.; Buhler, A.; Schlenk, R. F.; Groner, S.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 170 KB

## Purpose The phase II CLL2H trial evaluated safety and efficacy of subcutaneous alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia (CLL). Clinical and biologic markers were evaluated for their impacts on outcome. ## Patients and Methods One hundred nine patients